The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 24, 2019

Filed:

Jul. 11, 2017
Applicant:

Kiniksa Pharmaceuticals, Ltd., Wellesley, MA (US);

Inventors:

Heather A. Arnett, Seattle, WA (US);

Sabine S. Escobar, Sammamish, WA (US);

Chadwick T. King, North Vancouver, CA;

Ai Ching Lim, Mercer Island, WA (US);

Saravanakumar Narayanan, Brookline, MA (US);

Paul H. Weinreb, Weston, MA (US);

Nels E. Pederson, Mansfield, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/24 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); A61K 39/395 (2013.01); C07K 16/244 (2013.01); C07K 16/248 (2013.01); C07K 16/28 (2013.01); C07K 2317/21 (2013.01); C07K 2317/515 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

The invention provides anti-oncostatin M receptor-β (OSMR) antigen binding proteins, e.g., antibodies and functional fragments, derivatives, muteins, and variants thereof. OSMR antigen binding proteins interfere with binding of OSM and/or IL-31 to OSMR. In some embodiments, anti-OSMR antigen binding proteins are useful tools in studying diseases and disorders associated with OSMR and are particularly useful in methods of treating diseases and disorders associated with OSMR and binding of OSM and/or IL-31 to OSMR.


Find Patent Forward Citations

Loading…